For decades, the WABC newscaster encouraged other families facing the disease to hold onto hope. Now, he finds himself ...
The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...
The 76-year-old journalist went public with his diagnosis last month, saying his first symptom was “forgetting people’s names ...
"SuperAgers" keep razor-sharp memories past 80, but a new study shows this is not just down to good genes.
Laredo dementia specialist Jose Angel Hernandez wrote a children's book to help families discuss Alzheimer's disease with ...
Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...
Doctors at the Alzheimer's Research Center at Columbia are pinpointing where the disease begins and how it progresses. Imagine a raging fire that destroys a home. Investigators are searching for the ...
People who lived within 50 km of a coal-fired power plant were 72.9% more likely to develop Alzheimer’s disease pathology ...
With so many unknowns, Biogen is carefully eyeing its next-gen Alzheimer’s treatment diranersen as a high-risk, high-reward ...
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.
Hopes that the first drugs shown to slow Alzheimer’s disease could be rolled out on the NHS have risen after a second manufacturer entered price negotiations. US drugmaker Eli Lilly and Company, which ...
Heavy TV viewers had smaller brain volumes and white matter damage tied to cognitive decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results